Opdivo 240 MG/24 ML vial 24ML
Ended Awarded
- Contract number
- SPE2DB25FCYXN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,814
Award facts
- Contract value 100% obligated
- $29,813.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $29,813.58 to AmerisourceBergen Drug Corp for the supply of OPDIVO 240 mg/24 ml vials on July 25, 2025, with an ultimate completion date of August 15, 2025. This is a firm fixed price contract with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a wide range of pharmaceutical products and medical supplies to military and veteran healthcare systems through its DLA contracts. OPDIVO is a brand-name oncology medication commonly used in cancer immunotherapy treatment. As a primary vendor within DLA's pharmaceutical supply chain, AmerisourceBergen fulfills delivery orders across multiple therapeutic domains, demonstrating its capability to meet federal medical procurement requirements through both small-value and substantial pharmaceutical orders. The company serves various government healthcare systems, including the Defense Health Agency and U.S. Coast Guard, supporting military medical operations globally.
Quick answers
Who was awarded contract SPE2DB25FCYXN?
SPE2DB25FCYXN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 25, 2025.
How much is contract SPE2DB25FCYXN worth?
The government has obligated $29,814 on SPE2DB25FCYXN.
Is contract SPE2DB25FCYXN an order under another contract?
Yes. SPE2DB25FCYXN is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FCYXN competed?
The extent of competition for SPE2DB25FCYXN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award